3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Histiocytosis
1
Head and Neck Neoplasms
1
Glioblastoma
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Ipilimumab
10
tremelimumab
6
durvalumab
5
Nivolumab
3
pembrolizumab
2
tilsotolimod
1
spartalizumab
1
relatlimab
1
folfirinox
1
balstilimab
1
Vemurafenib
1
Vaccines
1
Radiotherapy
1
Radiofrequency Ablation
1
Radiation
1
Paclitaxel
1
Oxaliplatin
1
Opdualag
1
Melphalan
1
Leucovorin
1
Fluorouracil
1
Docetaxel
1
Cryosurgery
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diabetes Mellitus, Insulin-Dependent, 12
×
Immunotherapy
×
Clear all
No trials found.